author-photo

Leisha A. Emens

Johns Hopkins University
Johns Hopkins University School of Medicine

151

Papers

8856

Citations

Citation Trend

Filter By

Papers (151) Sort By

Journal Conference Others

Abstract OT-03-02: Phase 1/2 study of a novel HER2 targeting TLR7/8 immune-stimulating antibody conjugate (ISAC), BDC-1001, as a single agent and in combination with an immune checkpoint inhibitor in patients with advanced HER2-expressing solid tumors

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)
127TiP Phase II, open-label study to evaluate the safety and efficacy of praluzatamab ravtansine (CX 2009) in metastatic HR-positive/HER2 non-amplified breast cancer (mHR+/HER2− BC) and CX-2009 as monotherapy and in combination with pacmilimab in metastatic triple-negative breast cancer (mTNBC)

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
329TiP KATE3: A phase III study of trastuzumab emtansine (T-DM1) in combination with atezolizumab or placebo in patients with previously treated HER2-positive and PD-L1–positive locally advanced or metastatic breast cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
QSPIO-TNBC: A Quantitative Systems Pharmacology Platform in Immune-Oncology for Triple-Negative Breast Cancer

2021
Show All
- Source
- Cite
- Save
Citations (0)
Perspectives in immunotherapy: meeting report from the immunotherapy bridge (December 2nd-3rd, 2020, Italy).

2021 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PS9-15: Utilizing education to strengthen oncologist' understanding of immunotherapy in triple negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD14-05: Genomic profiling and clinical outcomes with first-line atezolizumab and nab-paclitaxel in triple-negative breast cancer: An exploratory analysis from the phase 3 IMpassion130 trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PS1-10: Outcomes after sentinel lymph node biopsy and radiation therapy in women over 70 years old with ER+, HER2-, clinically node negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
209P Interim results of a phase I/Ib study of SBT6050 monotherapy and pembrolizumab combination in patients with advanced HER2-expressing or amplified solid tumors

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-32-01: A phase 2, open-label study of bintrafusp alfa monotherapy in patients withHMGA2-expressing triple-negative breast cancer

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)